MRNA Oct 2024 95.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 02:05PM EDT. Market open.
| Previous Close | 58.00 |
| Open | 58.00 |
| Bid | 52.15 |
| Ask | 54.20 |
| Strike | 95.00 |
| Expire Date | 2024-10-18 |
| Day's Range | 58.00 - 58.00 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 56 |
ACCESSWIREModerna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
mRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and older Higher efficacy was observed in mRNA-1283 compared ...
Investor's Business DailyIs Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Moderna stock is trading sideways despite a bevy of news, including FDA approval for its RSV vaccine. Is MRNA stock a buy right now?
Yahoo FinanceModerna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
Moderna revealed its combination flu/COVID vaccine performed better than the two shots independently.
© 2024 Yahoo. All rights reserved.